Can low EPA, a high AA/EPA ratio, elevated ApoB particles, and monocyte-recruitment genetic susceptibility sustain vascular inflammation?

The intersection of lipid imbalances and specific genetic predispositions can establish a self-sustaining cycle of vascular wall inflammation and innate immune activation.

Lipid-driven endothelial signaling

• Eicosanoid shifting: A low EPA state combined with a high arachidonic acid (AA)/EPA ratio increases pro-inflammatory substrates (such as PGE2, TxA2, and LTB4). This upregulates NF-kB, COX-2, vascular cell adhesion molecule-1 (VCAM-1), and monocyte chemoattractant protein-1 (MCP-1) in endothelial cells.
• ApoB penetration: Elevated apolipoprotein B (ApoB)-containing lipoproteins penetrate and accumulate in the subendothelial space. Their oxidation and aggregation directly activate endothelial cells, promoting adhesion molecule and chemokine expression. This response is further amplified by a high AA/EPA ratio.

Genetic susceptibility and immune recruitment

• Amplified leukocyte signaling: The loss-of-function SH2B3 rs3184504 variant reduces the negative regulation of cytokine pathways, enhancing leukocyte inflammatory signaling and Th1-type immune responses.
• Enhanced chemotaxis and foam cell formation: Genetic variants in CCL2/MCP-1 (such as rs1024611) accelerate monocyte chemoattraction. Activated endothelial cells secrete CCL2 and express VCAM-1 to recruit these monocytes into the intima.
• Phenotypic transition: Retained ApoB particles deliver lipid cargo to subendothelial monocytes, while free AA is taken up by monocytes. Together, these lipids drive cells toward a pro-atherogenic, foamy phenotype.

Bottom line

• The convergence of a high AA/EPA ratio, elevated ApoB, and genetic risk variants (SH2B3 and CCL2) creates a feed-forward loop where lipid-induced endothelial injury and genetic susceptibility perpetually drive monocyte recruitment, foam cell formation, and chronic vascular inflammation.